NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ:REGN) on behalf of Regeneron stockholders. Our investigation concerns whether Regeneron has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
Regeneron is the subject of a DOJ lawsuit filed on April 10, 2024. The lawsuit accuses Regeneron of failing to report millions of dollars ...